Effects of intravenous administration of recombinant human erythropoietin in rats subject to hemorrhagic shock
- PMID: 8289996
- DOI: 10.1159/000187526
Effects of intravenous administration of recombinant human erythropoietin in rats subject to hemorrhagic shock
Abstract
The effects of recombinant human erythropoietin (rHuEPO) on survival and blood pressure in hypovolemic hemorrhagic shock in rats have been studied by intravenous administration. The hormone caused an increase in the time of survival compared to the group of rats without treatment (102 +/- 4.5 vs. 25 +/- 4.5 min, p < 0.01, vehicle; 102 +/- 4.5 vs. 25 +/- 2 min, p < 0.01, saline solution) and an increase in the percentage of the surviving animals (5/7 after 120 min vs. 0/7, p < 0.05). The animals treated showed an increase in mean arterial pressure that was not present in the control group. Through their data, the authors suggest the vasopressor effect of erythropoietin. Furthermore, from other studies done before, they hypothesize that the vasoactive ability of the hormone is endothelin mediated.
Similar articles
-
The effect of erythropoietin on microcirculation perfusion and tissue bioenergetics of the small intestine in a hemorrhagic shock and resuscitation rat model.J Trauma. 2010 Jun;68(6):1342-8. doi: 10.1097/TA.0b013e3181d27dbe. J Trauma. 2010. PMID: 20539178
-
Recombinant human erythropoietin improves gut barrier function in a hemorrhagic shock and resuscitation rat model.J Trauma. 2011 Nov;71(5 Suppl 1):S456-61. doi: 10.1097/TA.0b013e318232e782. J Trauma. 2011. PMID: 22072003
-
[The effects of intrarenal infusion of recombinant human erythropoietin on renal hemodynamics and renal function in anesthesized rabbits].Nihon Jinzo Gakkai Shi. 1993 Feb;35(2):125-31. Nihon Jinzo Gakkai Shi. 1993. PMID: 8315876 Japanese.
-
Effect of subcutaneous and intraperitoneal administration of recombinant human erythropoietin on blood pressure and vasoactive hormones in patients on continuous ambulatory peritoneal dialysis.Nephron. 1991;57(4):394-400. doi: 10.1159/000186302. Nephron. 1991. PMID: 1828543 Clinical Trial.
-
TSC and hemorrhagic shock.Adv Exp Med Biol. 2003;540:55-60. doi: 10.1007/978-1-4757-6125-2_9. Adv Exp Med Biol. 2003. PMID: 15174602 Review. No abstract available.
Cited by
-
Bench to bedside: A role for erythropoietin in sepsis.Crit Care. 2010;14(4):227. doi: 10.1186/cc9049. Epub 2010 Aug 6. Crit Care. 2010. PMID: 20727227 Free PMC article. Review.
-
Erythropoietin improves skeletal muscle microcirculation and tissue bioenergetics in a mouse sepsis model.Crit Care. 2007;11(3):R58. doi: 10.1186/cc5920. Crit Care. 2007. PMID: 17509156 Free PMC article.
-
Recombinant human erythropoietin inhibits iNOS activity and reverts vascular dysfunction in splanchnic artery occlusion shock.Br J Pharmacol. 1999 May;127(2):482-8. doi: 10.1038/sj.bjp.0702521. Br J Pharmacol. 1999. PMID: 10385249 Free PMC article.